Best Essential Oils for Eczema: Evidence and Skin Safety

Oils, extracts and formulated creams for eczema

Some plant-based preparations have human studies, while other claims rest on cells or animal models. The material, comparator and outcome determine what each result can support. These comparisons add the individual findings, including negative results and reports of harm, to the shared eczema-care advice.

Bergamot and eczema

We did not locate a controlled human trial showing that bergamot essential oil improves atopic eczema. Studies of its smell, mood effects or antimicrobial activity do not establish relief of an itchy, inflamed skin condition. Nor does evidence about other citrus oils answer the bergamot question.

A human skin-cell experiment found that bergamot affected proteins involved in inflammation and tissue remodelling. It also inhibited cell proliferation. These are experimental measurements, not evidence that an eczema patch healed or that long-term use is safe.

The clinical literature does contain relevant harm reports. A report of two patients describes blistering phototoxic reactions after bergamot aromatherapy exposure followed by ultraviolet exposure. Bergamot can contain light-reactive furocoumarins, including bergapten. These reactions are different from an ordinary eczema flare and do not require the same mechanism as contact allergy.

A separate clinical report describes allergic contact dermatitis involving lavender oil and cross-reaction with bergamot in an aromatherapist. Its indexed record does not provide an abstract, so it cannot support a detailed estimate of risk here. Case reports establish that reactions can occur, not how often they occur.

A product described as furocoumarin-free addresses a particular phototoxicity concern; that label is not clinical evidence of eczema benefit or a guarantee against irritation and allergy. There is no demonstrated reason to add bergamot fragrance to an emollient that is otherwise tolerated.

Related: Bergamot profile.

Eucalyptus and eczema

Eucalyptus has relevant human research, but its preparations need to be named accurately. A 44-person study compared a moisturising gel containing a synthetic ceramide-like ingredient and eucalyptus extract with no moisturiser. Both groups improved in some measures as summer progressed; the treated group had greater improvement in dryness. Because there was no matching moisturiser control, the study cannot isolate the extract from the benefit of moisturising.

A 19-person, four-week study made a stronger comparison: each participant used moisturisers with and without the ceramide-like ingredient and eucalyptus extract on opposite arms. Both improved visible skin symptoms and hydration. The formulation containing both ingredients also improved measured barrier function, ceramide levels and sweating responses. However, two ingredients changed together, so the findings do not identify eucalyptus extract’s independent contribution.

These extracts are not bottled eucalyptus essential oil. A separate 40-person cosmetic study tested blends containing eucalyptus, lavender and tangerine, with or without tea tree oil. It reported favourable skin-barrier and hydration measurements for the four-oil combination, without reported unwanted effects over 90 days. It did not establish eucalyptus alone as a treatment for atopic eczema.

An essential-oil experiment in mice and cells found reduced allergic swelling and effects on mast-cell signalling. An experimentally induced immediate allergic reaction is not the same as chronic human eczema. Taken together, these studies justify further work on specified formulations, not homemade eucalyptus additions to creams or substitution for prescribed treatment.

Related: Eucalyptus profile.

Frankincense and eczema

A 2014 double-blind trial compared a boswellic-acid formulation, bilberry seed-oil cream and placebo over 30 days. The 59 participants included people with psoriasis and people with eczema, so the individual eczema groups were small. The boswellic-acid cream improved reported itch and redness relative to placebo. It was a formulated Boswellia resin extract with lecithin, not distilled frankincense oil.

The study was short, and two authors worked for the product manufacturer. Its eczema severity table marks comparisons with each group’s own baseline; those changes should not all be described as direct proof of superiority over placebo. The report also contains inconsistent eczema group counts and percentages, limiting confidence in precise response estimates.

A 2022 report involving 71 participants described better outcomes with a Boswellia-containing product than placebo after six weeks. Eczema and psoriasis were discussed together, and reporting of the preparation and disease-specific results was limited. This is an additional preliminary extract-product finding, not an essential-oil trial.

Frankincense was also among the oils chosen in the small childhood massage study discussed below. Adding individually selected oils did not significantly outperform massage alone, and the study could not isolate frankincense. An indexed clinical report of contact dermatitis from frankincense oil adds a safety caution, although its full case details were unavailable for this review. We did not locate a controlled human frankincense-essential-oil-only eczema trial.

Related: Frankincense profile.

Geranium and eczema

A 2013 rose-geranium experiment found reduced swelling in mice after chemically induced paw or ear inflammation. The paw experiment used oral administration; the ear experiment used topical application. Neither measured eczema symptoms in people. A reduction in short-term swelling cannot establish long-term control of a relapsing skin disease.

A study of ten essential oils in human skin cells found that geranium inhibited cell proliferation. Human-derived cells are still a laboratory model, not patients whose itching, sleep or eczema severity has improved. Inhibition of cell growth or an inflammatory marker should not automatically be described as skin repair.

A 2024 preliminary report on geranium flower oil includes antimicrobial, antioxidant and enzyme tests alongside an animal gel experiment. The accessible version was labelled as awaiting peer review. Its authors discuss potential use in atopic dermatitis, but this does not turn the animal and laboratory findings into a human treatment trial.

We did not locate a controlled human trial establishing geranium essential oil alone for atopic eczema. Rose geranium is a Pelargonium product; studies of plants called Geranium or of rose oil cannot be transferred to it solely because their common names overlap. The existing laboratory results provide reasons to investigate a preparation, not evidence that adding fragrance to damaged skin is beneficial.

Related: Geranium profile.

Helichrysum and eczema

A 2023 study tested Corsican Helichrysum italicum oil and its component neryl acetate on donated human skin maintained outside the body. It found changes in genes and proteins involved in skin-barrier formation, with increased lipids and ceramides after five days. The work was supported by a cosmetics manufacturer and used a small number of donors.

These were skin explants, not a clinical trial in people with eczema. The study did not measure itching, sleep loss, flare frequency or whether treatment reduced the need for eczema medicines. Its specified Corsican oil also cannot represent every species or composition sold under the helichrysum name.

An earlier study found anti-inflammatory effects from isolated Helichrysum flavonoids in several laboratory and mouse models. One involved repeated chemical irritation described as experimental eczema. Isolated flavonoids and distilled essential oil are different preparations; the result does not demonstrate benefit from a retail oil.

An indexed case report describes allergic contact dermatitis attributed to Helichrysum italicum in an emollient cream. Full case details were unavailable here, so no frequency or dose estimate is inferred. We did not locate a controlled human helichrysum-essential-oil eczema trial. Promising barrier measurements and the possibility of contact allergy must both remain in the assessment.

Related: Helichrysum profile.

Rose and eczema

A study of rose-oil inhalation examined stress responses and skin-barrier measurements in rats and humans. In the human work, rose exposure limited stress-associated increases in water loss through the skin and salivary cortisol. This is relevant to the interaction between stress and skin, but it did not establish treatment of eczema symptoms, fewer flares or reduced need for prescribed medicines.

A separate formulation study in ten women tested a gel-cream containing both green-tea extract and rose oil. It reported favourable hydration and skin-barrier measurements. The small cosmetic study cannot isolate rose’s contribution, and improved hydration is not equivalent to controlling atopic inflammation.

There is also an indexed report of contact dermatitis from geraniol in Bulgarian rose oil. Only the bibliographic record was available for that report, so it is included as a documented safety signal without estimating how common such reactions are.

We did not locate a controlled human trial establishing rose essential oil alone as an eczema treatment. Rose essential oil, rose absolute and rosehip seed oil are different materials. Evidence about one does not establish the effects of another, and an inhalation study cannot supply instructions for applying fragrance to an eczema patch.

Related: Rose profile.

Thyme and eczema

A 2015 experiment in 45 mice compared lavender, thyme and a lavender-thyme blend across different treatment periods after chemically induced dermatitis. Several markers changed over time, and there were interactions between oil type and treatment duration. However, the abstract reports no significant overall difference between the three oil types. Describing the blend as definitively the best eczema treatment goes beyond that result.

The study’s nine groups combined three oils with three time points. It therefore does not provide the same evidence as a human trial with an otherwise identical vehicle control. Animal changes in immune markers or skin thickness cannot establish benefit, an application schedule or a safe home dilution for children.

A 2018 laboratory and mouse study found that isolated thymol reduced effects of membrane vesicles released by Staphylococcus aureus in an experimental dermatitis model. This is a narrower question about a bacterial contribution to inflammation. It did not show that whole thyme oil treats infected eczema in people.

Thyme was among the oils selected in the small childhood aromatherapy study below, which found no significant additional benefit over massage alone. The study did not isolate thyme. We did not locate a controlled human thyme-essential-oil-only eczema trial, and suspected infection needs clinical assessment rather than a homemade antimicrobial mixture.

Related: Thyme profile.

Turmeric and eczema

The human literature concerns several preparations. A 150-person open-label study of a polyherbal cream reported better eczema symptom scores after four weeks. There was no comparison group, so changes could not be attributed confidently to treatment or to an individual ingredient.

A 2015 controlled study involving 360 participants tested separate plant-extract formulations, including turmeric, Indian pennywort and walnut. It did not give all three plants together in every product. Ninety participants received turmeric across three formulation groups, with matched vehicle groups among the controls. The authors reported better symptom outcomes with the extract formulations. Follow-up lasted four weeks, and details of allocation and maintenance of blinding were limited. These were 5% extract products, not turmeric essential oil.

A 2026 trial in 64 adults compared a turmeric, henna and Aristolochia extract cream with its base for contact dermatitis. Severity and water-loss measurements favoured the mixture, but itch/discomfort and quality-of-life comparisons were not significant. One participant stopped because of a skin reaction. The preparation included Aristolochia and measurable aristolochic acid; the report’s short follow-up cannot establish long-term safety. This is not a recipe to reproduce or proof of turmeric alone for atopic eczema.

A 2024 preprint did test turmeric essential oil, but in rats with acetone-induced skin damage. It reported improvements in scratching and inflammatory measures. That early animal model is not human atopic eczema, and the report does not validate a home treatment.

Turmeric extracts, curcumin, culinary powder and distilled essential oil are not interchangeable. We did not locate a controlled human trial establishing turmeric essential oil alone for eczema. The extract studies deserve further investigation without assigning their results to an oil bottle.

Related: Turmeric profile.

What the small childhood massage study actually found

An eight-child study compared massage and counselling with or without individually selected essential oils, alongside normal medical treatment. Both groups improved, but adding oils did not significantly improve the result. Frankincense and thyme were among the oils selected; there were no separate treatment arms for individual oils.

During later treatment periods, eczema deteriorated in the oil-massage group. The authors raised possible contact allergy, while also discussing other explanations. The small study cannot establish which ingredient caused the change, but its longer-term finding should accompany the initial improvements. It provides no basis for a home massage-oil recipe for a child with eczema.

Keep established eczema care in place

NHS guidance recommends regular emollients and appropriate prescribed treatment, including topical corticosteroids when indicated. Seek GP advice if treatment is not helping. Painful, hot, swollen, blistered or leaking eczema, rapid worsening, pus or feeling unwell needs urgent GP or NHS 111 advice. The clinical diagnosis matters: atopic eczema, contact dermatitis and infection require different assessments.

A laboratory result is not a safe dilution instruction. Do not replace a tolerated emollient or prescribed treatment with essential oils, and do not treat a reaction to a scented product as a sign that it is working.

Search limitations: Targeted Europe PMC and web searches combined common and botanical names with eczema, atopic dermatitis, skin barrier and clinical-trial terms, followed by citation checks, completed 16 September 2026. This is an editorial review, not a systematic review or exhaustive unpublished-trial search. Full reports were checked for the 2014 Boswellia trial, 2022 Boswellia report, 2013 geranium mouse experiment, 2023 helichrysum explants, 2015 extract-formulation trial and 2026 contact-dermatitis trial. Other appraisals rely on indexed abstracts or clearly identified bibliographic case reports. Preliminary geranium and turmeric reports are identified separately; their peer-review status limits confidence. A further Thai eucalyptus-moisturiser report was located (PMID 35531798), but its full methods and results were unavailable for appraisal. Failure to locate a trial does not establish that none exists.

Basil and eczema: species, preparations and missing clinical evidence

Basil is the remaining candidate in this eczema review. Its wound-healing, cosmetic and sensitive-skin research needs to be separated from treatment of diagnosed eczema.

Basil and eczema

No controlled human trial establishing sweet basil essential oil as an eczema treatment was located. A basil-extract emulgel study reported improved wound healing in rabbits. A separate human cosmetic study tested a cream containing concentrated basil extract and measured skin hydration, water loss and surface features.

Neither was a clinical trial of distilled basil oil in people with eczema. Wound closure and cosmetic measurements cannot establish reduced eczema flares or reduced need for prescribed treatment. A registered holy-basil study is evaluating an oral extract supplement for stress-related sensitive-skin symptoms; it was recruiting with no results posted when checked on 16 September 2026. It cannot yet support an efficacy claim. Sweet basil, holy basil and African basil also refer to different species; findings about one preparation should not be assigned to every basil product.

A report of occupational allergic contact dermatitis from sweet basil was located. Its indexed record has no abstract, so detailed exposure and testing methods were not appraised. It is a safety signal rather than a measure of risk from any particular bottle. Keep established eczema treatment in place and avoid adding fragrance to a suspected product reaction.

Related: Basil profile.

Care in context

The NHS eczema guidance remains the appropriate care framework: regular tolerated emollients and prescribed anti-inflammatory treatment where needed. A product reaction is a reason to stop the suspected product and seek advice, not increase its concentration.

Search limitations: Targeted Europe PMC and web searches combined common and botanical plant names with the relevant skin condition, clinical trial, dermatitis, rash and wrinkle terms, with narrower follow-up searches and citation checks, completed 16 September 2026. This is an editorial review, not a systematic review or a complete unpublished-trial search. Indexed abstracts were used where full texts were unavailable; bibliographic-only allergy reports are identified in the text. Failure to locate a trial does not prove that none exists. Full texts were checked for the L-menthol, curcumin/tea tree emulgel and peppermint chronic-itch studies; the publisher report was checked for myrrh water extract. The bergamot UVB appraisal relies on its indexed abstract. The holy-basil registry was checked separately and has no results posted.

Formulation and allergy evidence both matter

Evidence update: 13 September 2026.

Chamomile nanoemulgel research was conducted in rats, not people using an ordinary oil. NCCIH notes potential chamomile allergy. The older extract-cream study does not justify replacing prescribed eczema treatment or adding fragrance to a well-tolerated emollient.

Include the sandalwood vehicle group when judging benefit

A positive uncontrolled sandalwood report should be read alongside the later randomised trial’s posted results. Eczema response proportions were similar with active and vehicle creams. This does not prove that every formulation is ineffective, but it weakens claims of established benefit. Neither trial justifies adding bottled oil to an emollient or replacing prescribed eczema care.

Nickel experiments do not establish atopic eczema treatment

Evidence update: 14 September 2026.

The experimental contact dermatitis study reported reduced nickel reactions, but not equivalent benefits for irritation or histamine-related itch. An earlier study found no significant effect from a 5% lotion. These results do not validate bottled tea tree oil for atopic eczema, especially given recognised contact allergy.

Separate virgin oil from newer coconut-derived creams

The 117-child virgin coconut oil trial reported better eczema scores than mineral oil. Newer coconut- and sunflower-derived cream research concerns a different formulation: itch results were favourable, but the quoted EASI comparisons were not statistically significant. Neither is evidence for treating infected eczema without assessment.